160 related articles for article (PubMed ID: 11880472)
21. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
[TBL] [Abstract][Full Text] [Related]
22. p53 expression and K-ras mutation in colorectal adenomas.
Scott N; Bell SM; Sagar P; Blair GE; Dixon MF; Quirke P
Gut; 1993 May; 34(5):621-4. PubMed ID: 8504962
[TBL] [Abstract][Full Text] [Related]
23. [Colon cancer: molecular markers].
Arnold CN; Blum HE
Dtsch Med Wochenschr; 2005 Apr; 130(14):880-2. PubMed ID: 15800822
[No Abstract] [Full Text] [Related]
24. [Colorectal cancer screening based on quantitative determining of fecal hemoglobin and transferrin].
Filimonov AV; Kotlyarov EV; Bilan EV
Vopr Onkol; 2015; 61(6):994-7. PubMed ID: 26995994
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
Nagasaka T; Yamaguchi Y
Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
[TBL] [Abstract][Full Text] [Related]
26. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and genetic screening of colorectal cancer.
Rustgi AK
Gastroenterology; 1995 Sep; 109(3):1003-5. PubMed ID: 7544749
[No Abstract] [Full Text] [Related]
28. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
Eguchi S; Kohara N; Komuta K; Kanematsu T
Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
[TBL] [Abstract][Full Text] [Related]
30. Tumor location and detection of k-ras mutations in stool from colorectal cancer patients.
Frattini M; Balestra D; Pilotti S; Bertario L; Pierotti MA
J Natl Cancer Inst; 2003 Jan; 95(1):72-3; author reply 73. PubMed ID: 12509403
[No Abstract] [Full Text] [Related]
31. Screening with a fecal multitarget DNA test.
Young GP; Worthley DL
Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
[No Abstract] [Full Text] [Related]
32. [The molecular screening of the stool for the colorectal carcinoma].
Voboril R; Weberová J; Dvorák J
Rozhl Chir; 2005 Jun; 84(6):281-5. PubMed ID: 16149221
[TBL] [Abstract][Full Text] [Related]
33. Comparing fecal immunochemical tests: improved standardization is needed.
Allison JE; Fraser CG; Halloran SP; Young GP
Gastroenterology; 2012 Mar; 142(3):422-4. PubMed ID: 22281273
[No Abstract] [Full Text] [Related]
34. Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer.
Rennert G; Kislitsin D; Brenner DE; Rennert HS; Lev Z
Cancer Lett; 2007 Aug; 253(2):258-64. PubMed ID: 17349741
[TBL] [Abstract][Full Text] [Related]
35. Group defines directions for colorectal cancer screening.
Smigel K
J Natl Cancer Inst; 1994 Jul; 86(13):958-60. PubMed ID: 7911845
[No Abstract] [Full Text] [Related]
36. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP
Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704
[TBL] [Abstract][Full Text] [Related]
37. An overview of colorectal cancer screening.
Goodbrand SA; Steele RJ
Scott Med J; 2008 Nov; 53(4):31-7. PubMed ID: 19051662
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
39. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
[TBL] [Abstract][Full Text] [Related]
40. Stool test for colorectal cancer screening: what is going on?
Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
